Status:
RECRUITING
Quantitative Assessment of Signal Loss in Cardiotocography Using External Recording
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Maternal Heart Rate
Eligibility:
FEMALE
18-45 years
Brief Summary
Signal loss in cardiotocography (CTG) recordings is numerous and frequent, whether due to artifacts in signal acquisition or confusion over inadvertent maternal heart rate recording, with various nega...
Eligibility Criteria
Inclusion
- Adult female (≥ 18 years old)
- Patient treated at a hospital between February 1, 2024 and February 28, 2024
- Having undergone cardiotocography in the labor and delivery room
- Gestational age at delivery \>36 weeks
Exclusion
- Patient who has expressed opposition to the use of medical record data
- Patient without CTG
- Gestational age at delivery \<36 weeks
Key Trial Info
Start Date :
February 22 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 22 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06906744
Start Date
February 22 2024
End Date
December 22 2025
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Gynécologie-Obstétrique CMCO - CHU de Strasbourg - France
Strasbourg, France, 67091